LLY Lilly (Eli)
Permanent stock page ↗Health Care · S&P 500
Next earnings: not announced yet
What 35 analyst firms say about Lilly (Eli): their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
34 rated views · 36 analyst/firm records · 35 firms
Radar score
- S&P 500 · Top Picks · 6MBelow the Radar threshold of 8055
- S&P 500 · Safest consensus · 6MBelow the Radar threshold of 8066
Recent analyst activity · last 90 days
Our tracked history has 37 reports on LLY from 27 analyst firms in the last 90 days (36 firms in the past year).
Comparing each firm's latest target with its previous one: 20 raised their price target, 2 left it unchanged and 4 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Cantor Fitzgerald raised its target from $1,440.00 (set 8 Oct 2026) to $1,600.00 on 2 Nov 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Argus | Jasper Hellweg | Buy | 30 Oct 2026 | 1,550.00 USD |
| Bank of America Securities | Jason Gerberry | Buy | 30 Oct 2026 | 1,497.00 USD |
| Barclays | Emily Field | Buy | 21 Sep 2026 | 1,400.00 USD |
| Berenberg | Kerry Holford | Buy | 15 Sep 2026 | 1,400.00 USD |
| Bernstein | Courtney Breen | Buy | 26 Oct 2026 | 1,450.00 USD |
| BMO Capital Markets | Evan David Seigerman | Buy | 30 Oct 2026 | 1,650.00 USD |
| Cantor Fitzgerald | Carter Gould | Buy | 8 Oct 2026 | 1,440.00 USD |
| CICC | Unnamed analyst | Hold | 11 Feb 2026 | 1,107.00 USD |
| Citigroup | Geoff Meacham | Buy | 30 Oct 2026 | 1,650.00 USD |
| Daiwa | Narumi Nakagiri | Buy | 13 Aug 2026 | 1,410.00 USD |
| DBS | Nico Chen | Buy | 9 Sep 2026 | 1,550.00 USD |
| Deutsche Bank | James Shin | Buy | 6 Mar 2026 | 1,285.00 USD |
| DZ Bank | Elmar Kraus | Buy | 10 Aug 2026 | 1,351.00 USD |
| Erste Group | Hans Engel | Buy | 25 Jun 2026 | — |
| Evercore ISI | Umer Raffat | Hold | 1 Jul 2026 | — |
| Freedom Capital | Unnamed analyst | Buy | 10 Feb 2026 | — |
| Freedom Capital Markets | Ilya Zubkov | Buy | 13 Aug 2026 | 1,400.00 USD |
| Goldman Sachs | Asad Haider | Buy | 6 Aug 2026 | Conflicting reports · excluded |
| Guggenheim | Seamus Fernandez | Buy | 18 Sep 2026 | 1,284.00 USD |
| HSBC | Rajesh Kumar | Sell | 10 Sep 2026 | 940.00 USD |
| Jefferies | Akash Tewari | Buy | 30 Oct 2026 | 1,610.00 USD |
| JPMorgan | Chris Schott | Buy | 30 Oct 2026 | 1,650.00 USD |
| Leerink Partners | David Risinger | Buy | 21 Oct 2026 | 1,316.00 USD |
| Morgan Stanley | Terence Flynn | Buy | 30 Oct 2026 | 1,596.00 USD |
| National Bank Financial | Tim Anderson | — | 1 Dec 2025 | 1,286.00 USD |
| RBC Capital Markets | Trung Huynh | Buy | 30 Oct 2026 | 1,600.00 USD |
| Redburn | Simon Baker | Hold | 11 Aug 2026 | 915.00 USD |
| Scotiabank | Louise Chen | Buy | 30 Oct 2026 | 1,605.00 USD |
| TD Cowen | Steve Scala | Buy | 22 Sep 2026 | 1,250.00 USD |
| Truist | Robyn Karnauskas | Buy | 7 Aug 2026 | 1,376.00 USD |
| Truist | Srikripa Devarakonda | Buy | 30 Oct 2026 | 1,612.00 USD |
| UBS | Michael Yee | Buy | 30 Oct 2026 | 1,625.00 USD |
| Weiss Ratings | Unnamed analyst | — | 30 Oct 2026 | — |
| Wells Fargo | Mohit Bansal | Buy | 30 Oct 2026 | 1,500.00 USD |
| Wolfe Research | Alexandria Hammond | Buy | 14 Jul 2026 | 1,400.00 USD |
| Data feed RESEARCH | Research Team | Hold | 30 Jan 2026 | 1,250.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 03:58 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.